TBBPA does not result in "adverse consequences that might be deemed to be associated to disruptions in the endocrine system," according to the BBPA. Therefore, TBBPA should not be regarded as a "endocrine disruptor" in accordance with generally recognised definitions. Additionally, TBBPA has no chance of bioaccumulating because it is swiftly eliminated by animals. Tetrabromobisphenol A levels have been shown to be incredibly low in samples of human serum, human food, and household dust. Human daily TBBPA intakes were predicted to be under a few ng/kg bw/day. The general public's exposures are likewise much below the derived-no-effect-levels (DNELs) derived for REACH endpoints of possible concern. Studies reveal that TBBPA may interfere with development because it degrades to bisphenol A and TBBPA dimethyl ether.
Read More:
Click Here For the Tetrabromobisphenol A Market Press Release
Learn More About Tetrabromobisphenol A Market Through This Video
